Nucleolin (NCL) is an RBP overexpressed in BC, and tRF3E derived from tRNA-Glu can form a complex with NCL, thereby disrupting the inhibitory effect of NCL on p53 mRNA translation, leading to increased p53 expression and thus inhibiting tumor growth.147. Here, TP53 is linked to breast cancer.